Search Details

Word: zeneca (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...study, funded by Astra-Zeneca, the maker of rouvastatin, tested nearly 18,000 patients who had low levels of cholesterol but high levels of the reactive protein. According to Ridker, the reduction in heart disease risk was far greater than the researchers anticipated...

Author: By Jillian K. Kushner, CONTRIBUTING WRITER | Title: Study Finds Statins Reduce Heart Disease Risk | 11/21/2008 | See Source »

CRESTOR Dubbed the superstatin, this newest member of the cholesterol-lowering-drug family reduces blood lipid levels in some cases as much as 60%. The FDA approved Crestor in August, and maker Astra Zeneca plans to have it in pharmacies in the next few months...

Author: /time Magazine | Title: Medicine: Here's to Your Health | 9/8/2003 | See Source »

...cycles. Compared with P&G's core business, pharmaceuticals is very risky." Some observers think Procter should stick to the over-the-counter business, leveraging its marketing savvy and retail relationships to help bigger pharma companies roll out nonprescription versions of their drugs, as it is doing with Astra Zeneca for its heartburn medication, Prilosec. Fortunately, at least for the moment, Lafley shouldn't have much need for that kind of remedy. --With reporting by Daren Fonda/New York

Author: /time Magazine | Title: A Healthy Gamble | 9/16/2002 | See Source »

...Pharmaceuticals in Uniondale, N.Y., which is showing promise against some lung tumors as well as head and neck cancers. Neither of these compounds keeps EGF from docking with cells; instead, each worms its way inside the cells, where it intercepts growth messages percolating in from the surface. Astra Zeneca, headquartered in London, is testing a similar compound, Iressa, against some lung, stomach and prostate cancers...

Author: /time Magazine | Title: New Hope For Cancer | 5/28/2001 | See Source »

...Pharmaceuticals in Uniondale, N.Y., which is showing promise against some lung tumors as well as head and neck cancers. Neither of these compounds keeps EGF from docking with cells; instead, each worms its way inside the cells, where it intercepts growth messages percolating in from the surface. Astra Zeneca, headquartered in London, is testing a similar compound, Iressa, against some lung, stomach and prostate cancers...

Author: /time Magazine | Title: New Hope For Cancer | 5/28/2001 | See Source »

First | | 1 | 2 | Next | Last